The molecular networks that control endoplasmic reticulum (ER) redox conditions in mammalian cells are incompletely understood. Here, we show that after reductive challenge the ER steady-state disulphide content is restored on a time scale of seconds. Both the oxidase Ero1a and the oxidoreductase protein disulphide isomerase (PDI) strongly contribute to the rapid recovery kinetics, but experiments in ERO1-deficient cells indicate the existence of parallel pathways for disulphide generation. We find PDI to be the main substrate of Ero1a, and mixed-disulphide complexes of Ero1 primarily form with PDI, to a lesser extent with the PDI-family members ERp57 and ERp72, but are not detectable with another homologue TMX3. We also show for the first time that the oxidation level of PDIs and glutathione is precisely regulated. Apparently, this is achieved neither through ER import of thiols nor by transport of disulphides to the Golgi apparatus. Instead, our data suggest that a dynamic equilibrium between Ero1-and glutathione disulphidemediated oxidation of PDIs constitutes an important element of ER redox homeostasis.
Introduction
Regulation of the redox environment in the endoplasmic reticulum (ER) is emerging as an important aspect of cellular homeostasis (Malhotra and Kaufman, 2007; Merksamer et al, 2008) , and the thiol-disulphide oxidoreductases of the protein disulphide isomerase (PDI) family are central to ER redox control (Appenzeller-Herzog and Ellgaard, 2008b) . PDIs contain one or more thioredoxin-like domains. These typically harbour a CXXC active-site sequence motif required for the catalysis of thiol-disulphide exchange reactions, such as the introduction of disulphides into substrate proteins.
The identification in yeast of the essential ER-resident sulfhydryl oxidase Ero1p (Frand and Kaiser, 1998; Pollard et al, 1998) , which oxidizes PDI (Frand and Kaiser, 1999; Tu et al, 2000) and reduces molecular oxygen to hydrogen peroxide (Gross et al, 2006) , has led to an improved understanding of oxidative folding and ER redox regulation (Sevier et al, 2007; Sevier and Kaiser, 2008) . Consistent with an important function in ER protein oxidation, both human isoforms Ero1a and Ero1b are transcriptionally upregulated by the ER stress response Marciniak et al, 2004) , which can be associated with a reductive shift in the ER redox conditions (Nadanaka et al, 2007; Merksamer et al, 2008) . Moreover, the activity of Ero1a is subject to negative feedback regulation by intramolecular disulphide bonds (Appenzeller-Herzog et al, 2008; Baker et al, 2008) . The enzyme appears in at least three redox forms: reduced, OX1 and OX2 (Benham et al, 2000) . The latter is the most oxidized form with all regulatory disulphide bonds in place (Appenzeller-Herzog et al, 2008; our unpublished observations) . The cellular activation state of Ero1a is controlled by the availability of reduced PDI (Appenzeller-Herzog et al, 2008) , which can reduce the regulatory disulphide bonds (see also Discussion) (Sevier et al, 2007; Appenzeller-Herzog et al, 2008; Baker et al, 2008) . Ero1a also controls calcium fluxes from ER to mitochondria , which could correlate with its partial localization at mitochondria-associated ER membrane domains (Gilady et al, 2010) .
The dominance of Ero1 enzymes in providing the oxidizing equivalents for the synthesis of disulphides is, however, still a matter of debate (Thorpe and Kodali, 2010) . For instance, the slow in vitro rate of PDI oxidation by Ero1a (Baker et al, 2008; Wang et al, 2009 ) appears at odds with a principal function in disulphide-bond generation. Knockout of the single Ero1 gene in fruit fly causes a specific defect in Notch signalling while apparently leaving the bulk disulphide-bond repertoire unperturbed (Tien et al, 2008) . Most importantly, however, Ero1a and Ero1b appear non-essential in the mouse, as evidenced by the viability of an Ero1a/Ero1b double mutant (Zito et al, 2010) . Indeed, several possible Ero1-independent pathways for disulphide generation and/or the oxidation of PDI in the ER of mammalian cells exist (Margittai and Banhegyi, 2010) . These include the activity of quiescin-sulfhydryl oxidases (Thorpe and Kodali, 2010) , import of dehydroascorbate from the cytosol and its reduction by dithiol groups (Saaranen et al, 2010) , ER-luminal detoxification of NADPH oxidase 4-generated hydrogen peroxide (Santos et al, 2009 ) and a pathway that uses the oxidizing equivalents of radicals derived from mitochondrial respiration to generate disulphides in secretory compartments (Yang et al, 2007) . In analogy to a mechanism that operates in both archaea and bacteria (Dutton et al, 2008; Singh et al, 2008) , PDI could also be oxidized through the vitamin K cycle (Wajih et al, 2007) . Currently, we lack a thorough cell biological understanding of these pathways in relation to oxidative folding in the ER.
In addition to the PDIs and Ero1, glutathione also has a fundamental function in ER redox homeostasis. This low-molecular weight thiol compound exists as a mixture of reduced glutathione (GSH) and glutathione disulphide (GSSG). Cytosolderived GSH can enter the ER where its reducing power is required for the rearrangement of aberrant disulphide bonds in folding substrates (Chakravarthi et al, 2006) .
On these premises, we decided to further explore the links between Ero1, PDIs and glutathione in cultured human cells. Our work shows a very rapid production of disulphides in the ER whose velocity depends on both Ero1a and PDI, but apparently less so on other PDI-family members. In cells devoid of both Ero1a and b, however, we present evidence for Ero1-independent pathway(s) for thiol oxidation. Finally, we show that ER oxidation is tightly regulated and propose a mechanistic model of ER redox homeostasis that integrates previous and current findings.
Results

Thiol import and disulphide export have a minor function in acute ER redox control
Although it has been shown that Ero1 activity ultimately leads to the oxidation of GSH in the ER (Cuozzo and Kaiser, 1999; Appenzeller-Herzog et al, 2008) , the mechanisms that counteract the accumulation of ER-luminal GSSG are still unclear (Chakravarthi et al, 2006; Thorpe and Kodali, 2010) . As GSSG displays only low permeability through microsomal membranes (Banhegyi et al, 1999) , we tested whether export of GSSG through the secretory pathway might contribute to ER redox homeostasis. We, therefore, combined the pharmacological inhibition of ER-to-Golgi transport with ER redox state analysis. For this purpose, we used a combination of brefeldin A and monensin (BFA/mon), which blocks vesicular anterograde transport from the ER, while preserving the integrity of the Golgi apparatus (Barzilay et al, 2005; Supplementary Figure S1 ), and an assay in which oxidized active-site cysteines in PDIs are modified with 4-acetamido-4 0 -maleimidylstilbene-2,2 0 -disulphonic acid (AMS), resulting in slower mobility upon SDS-PAGE (Jessop and Bulleid, 2004) . Using this AMS shift assay, we have consistently found the redox distribution of various PDIs to exhibit molecules in both reduced and oxidized states (Haugstetter et al, 2005; Appenzeller-Herzog et al, 2008; AppenzellerHerzog and Ellgaard, 2008a; Roth et al, 2010) , the ratio of which can be used as a readout to monitor redox variations in the ER.
We studied the effect of BFA/mon treatment on the redox recovery of the PDIs TMX3 (a transmembrane PDI-family member) and ERp57 (a close homologue of PDI) upon application and washout of the oxidant diamide. No significant delay in the recovery was observed under conditions of blocked ER-to-Golgi transport ( Figure 1A and B). Hence, BFA/mon-sensitive vesicular export appears to be of minor importance as a redox-balancing mechanism against hyper-oxidizing conditions. Reestablishment of the ER redox state after washout of the oxidant dipyridyl sulphide is mediated by the import of GSH through the ER membrane (Jessop and Bulleid, 2004) . Further reductive input is brought to the ER through the co-translational translocation of protein thiols (Cuozzo and Kaiser, 1999) . For these reasons, we examined whether lowering cellular GSH levels by L-buthionine-sulfoximine (BSO) or the shutdown of translation by cycloheximide (CHX) altered the ER redox state. As shown in Figure 1C , neither of these drugs showed a consistent effect on the redox ratios of TMX3 and ERp57 at steady state. It should be noted that for reasons of cytotoxicity, we did not apply combinations of the above treatments so that additive effects between the different reductive pathways cannot be excluded. Still, these results suggested that mechanism(s) other than ER export of disulphides or import of thiols secure ER redox balance.
PDI withstands in situ reduction better than other ER oxidoreductases PDI is a known substrate of Ero1 (Sevier and Kaiser, 2008 2009). We, therefore, next investigated factors that could control the redox state of various PDI-family members. First, we determined their in vivo dithiothreitol (DTT) resistance by means of an assay where cells are challenged with increasing concentrations of this membrane-permeant reductant. Although the two separate active-site domains in PDI exhibit very similar reduction potentials (Darby and Creighton, 1995) , the susceptibility towards DTT-mediated in situ reduction of the a domain was greater than of the a 0 domain (Figure 2A ). The a 0 domain is preferentially oxidized in vitro by Ero1a (Baker et al, 2008; Wang et al, 2009) , which becomes activated by DTT through reduction of its regulatory disulphides (see below). Thus-although the DTT resistance readout could also be influenced by protein quaternary structure and differential accessibility of active-site cysteines to DTT or N-ethylmaleimide (NEM)-this result suggested that the DTT resistance of a PDI-family member's active site in the ER reflects its propensity to become reoxidized by ER-resident oxidases.
When comparing the in vivo redox states of TMX3 and ERp57 after treatment of cells with different concentrations of DTT, we observed a slightly higher DTT resistance of the AMS-shifted form of ERp57 (Figure 2B and C) . This form represents ERp57 with its a 0 domain oxidized, whereas ERp57 with exclusively the a domain oxidized virtually co-migrates with the reduced form (Appenzeller-Herzog et al, 2008) . Given that the active-site domains of ERp57 and TMX3 have approximately the same reduction potential (Frickel et al, 2004; Haugstetter et al, 2005) , these results indicated that in cells the relative rates of oxidation for the single active site in TMX3 and the a 0 active site in ERp57 are distinct. Still, the Ero1a-controlled active site in PDIa 0 by far displayed the highest cellular DTT resistance, likely underlining its importance as an electron donor for Ero1a in vivo.
Mixed-disulphide interactions of PDIs with Ero1a and Ero1b reflect their in vivo DTT resistance
To investigate a possible function of Ero1 in maintaining the levels of the oxidized fractions of ERp57 and TMX3, we searched for intracellular mixed-disulphide interactions. For this purpose, we performed co-immunoprecipitation experiments of myc-tagged Ero1a (Ero1amyc6his) or Ero1b (Ero1bmyc6his) stably expressed from a doxycyclin-inducible promoter (Appenzeller-Herzog et al, 2008) using an in situ acidification/in vitro NEM-alkylation protocol. Compared with in situ NEM trapping, the acidification method was much more effective in trapping mixed-disulphide interactors of Ero1 (data not shown).
As expected, PDI was readily precipitated with amyc in an Ero1amyc6his-dependent manner ( Figure 3A, lanes 3 and 4) , and non-reducing gel electrophoresis revealed a prominent Ero1amyc6his-PDI mixed-disulphide complex ( Figure 3A , lane 7). Unlike in a previous study that used NEM trapping of mixed disulphides (Mezghrani et al, 2001) , an interaction with Ero1amyc6his was also detected for ERp57 and ERp72 ( Figure 3B and C) . While the pool of PDI acid trapped in a covalent complex with Ero1amyc6his at steady state was 43% of total, the disulphide-linked fractions of ERp57 and ERp72 were only 0.5-2% (compare lane 4 to '1% of total', in lane 1). In contrast, we detected no co-immunoprecipitation of TMX3 ( Figure 3D ). The same pattern of mixed-disulphide interactions was also found for Ero1bmyc6his ( Figure 3 , lanes 5 and 8). In the case of ERp57, HA-tagged mutants with one active site changed to SXXS could both be acid trapped in a mixed-disulphide complex with Ero1amyc6his or Ero1bmyc6his (Supplementary Figure S2A) . As the cells were pulsed with 35 S-methionine for 1 h in the presence of doxycyclin and chased for 1 h without doxycyclin but in the presence of CHX, the detected mixed disulphide is unlikely to involve a folding intermediate of Ero1. The same result was obtained in the absence of CHX (data not shown). Autoradiography of the membranes used for western blotting documented the specificity of immunoprecipitation (Supplementary Figure S2B ). Taken together, Ero1a and b can form mixed disulphides not only with their known substrate PDI, but to a lesser extent also with ERp57 and ERp72, whereas TMX3 appears not to interact directly with either of the two oxidases.
Restoration of the ER redox balance is fast, precise and affected by Ero1 over-expression
We next sought to functionally dissect the roles of Ero1 and its interaction partners in ER oxidation by means of an oxidative recovery assay. In this assay, the cellular fraction of GSSG (which mainly represents GSSG in the ER; Appenzeller-Herzog et al, 2008 ) is recorded at different time points after DTT washout. The oxidative resetting of the steady-state ratio of GSSG to total glutathione (GS tot ) in HEK293 cells was very precise and displayed a half time of only B10 s ( Figure 4A ; Supplementary Figure S3A ). Similar recovery times were observed with a negative control cell line for doxycyclin-inducible over-expression of various Ero1 constructs (Supplementary Figure S3B ). In this cell line, the reacquisition of the steadystate redox ratio of TMX3 and ERp57 was also very fast, with reoxidation becoming visible as early as 5 s after washout of the reductant ( Figure 4B and data not shown).
To study the effect of over-expression of exogenous Ero1 variants on the recovery of GSSG after a reductive challenge, we next performed DTT washout experiments in the Ero1amyc6his-and Ero1bmyc6his-inducible cells. As expected, when doxycyclin was omitted, the rate of GSSG formation resembled the situation in non-transfected cells ( Figure 4C and D, control; for raw data see Supplementary Figure S3 ). In contrast, induction of Ero1amyc6his strongly modulated the process. The initial rate of GSH oxidation was apparently too fast to be assessed by our experimental setup so that around six times the steady-state GSSG levels were measured at the 0 s time point ( Figure 4C ). However, consistent with our previous finding that over-expression of Ero1amyc6his does not affect the cellular glutathione redox state (Appenzeller-Herzog et al, 2008) , the GSSG:GS tot ratio declined within 5 min to the steady-state value, indicating the reduction of excess GSSG to GSH.
In the case of Ero1bmyc6his over-expression, the peak in GSSG formation was clearly less prominent and did not occur until the 10 s time point ( Figure 4D ). These differences were not a result of lower expression levels of Ero1bmyc6his (Appenzeller-Herzog et al, 2008; Supplementary Figure S2B) , and neither were they evident when monitoring the redox states of TMX3 and ERp57 upon DTT washout (Supplementary Figure S3C) . We also used cell lines inducibly expressing two point mutants of Ero1a, Ero1amyc6his-C131A and Ero1amyc6his-C394A. Whereas the former cannot build a critical regulatory disulphide, the latter is a competitive inhibitor of ER oxidation (Appenzeller-Herzog et al, 2008) . Similar to Ero1amyc6his, Ero1amyc6his-C131A led to strong transient GSH hyper-oxidation ( Figure 4E ). Conversely, expression of Ero1amyc6his-C394A slightly impeded the rate of oxidative recovery ( Figure 4F ). Doxycyclin-induced and in situ acid-trapped negative control (Neg ctrl), Ero1amyc6his and Ero1bmyc6his cells were subjected to amyc immunoprecipitation (IP) followed by reducing (R) or non-reducing (NR) SDS-PAGE and western blot (WB) analysis using aPDI (A), aERp57 (B), aERp72 (C) or aTMX3 (D). The 35 S-signal recorded by phosphorimaging of one of the membranes is shown in Supplementary Figure S2B . As positive controls for western blotting, 1% of the Ero1amyc6his lysate (1% of total) as well as reduced and non-labelled HEK293 lysate (cold lysate) were loaded in lanes 1 and 2. The results are representative of two independent experiments. Filled arrowheads, monomeric PDIs; open arrowheads, dimeric mixed-disulphide complexes of PDIs with Ero1 (the precise mobility of which is unclear in the case of ERp72; indicated by a vertical line); asterisks, potential mixed-disulphide complexes of PDIs with Ero1a dimers; X, background bands.
Rapid oxidative recovery depends on Ero1 and PDI
The stimulation of ER reoxidation by exogenous Ero1 implied that endogenous Ero1 may catalyse the fast rate of disulphide-bond reformation upon DTT washout in non-transfected cells. To examine this, we first downregulated the expression of Ero1a in HEK293 cells by siRNA transfection. Partial knockdown of Ero1a slightly delayed ER reoxidation as assessed by timed redox analysis of TMX3 and ERp57 (Supplementary Figures S4A-C) . Next, we performed DTT washout experiments in embryonic fibroblasts derived from homozygous double mutant mice that harbour disruptive viral insertions in the genes encoding Ero1a and Ero1b (Zito et al, 2010) . In keeping with the lack of Ero1a detection in double mutant cells ( Figure 5A ), we observed a strong delay in ER reoxidation ( Figure 5B and C). The steady-state redox distribution of ERp57, however, was not affected by Ero1 deficiency ( Figure 5B ). Unfortunately, these cells were not amenable to redox analysis of TMX3, because AMS modification only minimally shifts the electrophoretic mobility of mouse TMX3 (data not shown). We also assessed the reformation of GSSG during oxidative recovery from DTT in wild-type versus double mutant fibroblasts. Unexpectedly, the GSSG:GS tot ratio promptly increased upon DTT washout not only in wild type but also in the mutant cells, whereas complete reoxidation of GSH after a recovery period of 300 s was only achieved in wild-type cells ( Figure 5D ). Furthermore, the resting value for GSSG:GS tot was higherthat is more oxidizing-in double mutant cells ( Figure 5D , inset). These findings argue that at least one Ero1-independent pathway for GSH oxidation is operative in these cells.
We next investigated whether the efficient delivery of disulphide bonds in the ER depended on PDI. Indeed, for TMX3, ERp57 and glutathione, the oxidative recovery was clearly impaired in cells stably depleted of PDI (knockdown efficiency B90%; see Ou and Silver, 2006; AppenzellerHerzog et al, 2008) as compared with control cells ( Figure  5E -G). Thus, PDI has a prominent function in oxidative recovery and the direct interactions of ERp57 or ERp72 with Ero1a ( Figure 3 ) cannot efficiently substitute the supply of disulphide bonds through the Ero1a-PDI relay. Nonetheless, the diminished rate of GSSG:GS tot recovery in murine ERp57À/À cells (Garbi et al, 2006) suggested that early after DTT washout ERp57 does contribute to the shuttling of disulphide bonds to GSH ( Figure 5H ).
So far, the data indicated that upon reductive challenge the propagation of Ero1-generated oxidative equivalents through PDI to the ER thiol pool was a rapid process. We, therefore, expected the complex between the two enzymes to form quickly after DTT treatment. To investigate this, we performed co-immunoprecipitation experiments using cells that had been challenged with DTT. Hence, doxycyclin-induced Ero1amyc6his or Ero1bmyc6his cells were treated with DTT or left untreated, washed with ice-cold phosphate-buffered saline (PBS) and covered with trichloroacetic acid (TCA) followed by amyc immunoprecipitation. Co-immunoprecipitated PDI was readily detectable even after DTT treatment (Figure 6A, lanes 12, 14, 16 and 18) , indicating the formation of the Ero1-PDI mixed-disulphide complexes to be extremely rapid. We suggest that this rapid process reflects the sulfhydryl oxidase activity of Ero1, and that this in turn accounts for the high apparent DTT resistance of the PDIa 0 active site (Figure 2A) . Notably, when analysed under non-reducing conditions, the Ero1-PDI complexes isolated from DTT-treated cells migrated more slowly in the gel than when isolated from non-treated cells ( Figure 6A , Ero1 þ PDI RED.), a finding that was recapitulated for the endogenous proteins ( Figure 6B ). This suggested that in untreated cells, the bulk of Ero1 that is covalently attached to PDI is in an oxidized or partially oxidized state. We also found the mixed-disulphide complex between PDI and Ero1a from DTT-treated cells to require the active-site Cys 94 in Ero1a ( Figure 6C ). Figure S4D ). For unknown reasons, GSSG:GS tot rises above the steady-state value after 300 s of oxidative recovery in wild-type cells. The GSSG:GS tot ratios in Ero1 wild-type and double mutant MEFs at steady state are shown in the inset (n ¼ 12). (E) Redox state analysis of TMX3 and ERp57 after DTT washout performed as in Figure 4B , but using PDI shRNA clones 5-1 (control cells) and 4-1 (PDI knockdown (kd) cells). Open arrowheads indicate the delayed formation of oxidized TMX3/ERp57 upon knockdown of PDI.
(F) Densitometric analysis of (D) (n ¼ 3, mean ± s.
d.). (G, H)
The oxidative recovery of GSSG:GS tot after DTT washout was determined as in panel D using clone 5-1 (control) and clone 4-1 (PDI kd) cells (G) or 2175 þ (control) and 2175 À (ERp57 ko) cells (H) (mean ± s.d., two independent experiments each performed in triplet; Supplementary Figure S4E and F). For unknown reasons, GSSG:GS tot rises above the steady-state value after 300 s of oxidative recovery in 2175 þ and 2175 À cells. *Po0.05; **Po0.01; ***Po0.001 (Student's t-test). Figure S5 ). Overall, the findings showed that Ero1, when activated by DTT in situ, efficiently established a catalytic interaction with PDI.
Discussion
A molecular model for ER redox balance: interplay between Ero1 and glutathione
Although Ero1p is essential in yeast, the principal pathway for disulphide-bond generation in the ER of metazoans is still unclear (Tien et al, 2008; Thorpe and Kodali, 2010; Zito et al, 2010) . Furthermore, the concept of disulphide delivery to reduced substrate proteins and GSH through Ero1-PDI relay has been questioned because it potentially leads to the futile depletion of cellular reductants accompanied by the accumulation of ER-luminal GSSG and hydrogen peroxide (Thorpe and Kodali, 2010) . The data presented herein provide new insight on the significance and the precise regulation of disulphide generation by Ero1. We show that reoxidation of PDI-family members and GSH after reductive challenge is very fast. The recovery process is hampered by genetic ablation of Ero1 and by knockdown of PDI, indicating that the Ero1-PDI disulphide relay represents an important pathway for the production of disulphide bonds in the ER of mammalian cells. In most cell types including mouse embryonic Figure 6 Upon reductive challenge, activated Ero1a rapidly reacts with PDI. (A) Co-immunoprecipitation performed in analogy to the experiment presented in Figure 3A except that, where indicated, cells were treated with DTT ahead of TCA lysis. A phosphoimager scan (IP: amyc (Ero1)) and a western blot (WB) using aPDI are shown. The mobility differences between the Ero1-PDI mixed-disulphide complexes (Ero1 þ PDI) under steady-state conditions (OX.) and upon DTT-mediated reduction (RED.) are marked. For unknown reasons, the intensity of WB detection of Ero1 þ PDI did not reflect the relative intensities observed by phosphorimaging. Note that an NEM-and redox state-dependent mobility shift of Ero1a in reducing SDS-PAGE (compare lanes 2 and 3; see also panel B, WB: aEro1a) has been reported previously (Benham et al, 2000) . The result is representative of two independent experiments. Filled arrowhead, monomeric PDI; asterisks, Ero1a/bmyc6his-ERp57 mixed-disulphide complex (inferred from Supplementary Figure S5) ; X, background band. (B) TCA pellets from HEK293 cells incubated with DTT or left untreated were solubilized/neutralized in the presence of NEM, and Ero1a was precipitated from the lysate using ConA-sepharose (Benham et al, 2000) . The precipitate was boiled under reducing (R) or non-reducing (NR) conditions and analysed by aPDI western blotting (WB, left panel). After stripping, the membrane was probed with aEro1a (right panel). The mobilities of PDI, the known monomeric redox forms of Ero1a (R, OX1, OX2; visible upon contrast enhancement) and of the Ero1a þ PDI complex (both RED. and OX.) are indicated. The results are representative of three independent experiments. Asterisk, potential mixed-disulphide complex of PDI with an Ero1a dimer; double asterisk, unidentified, DTT-resistant mixed-disulphide complex. (C) Phosphorimager scan of a co-immunoprecipitation experiment performed as in panel A. In addition to doxycyclin-induced Ero1amyc6his cells (dox), HEK293 transiently transfected (cDNA) with pcDNA3/ Ero1amyc6his or pcDNA3/Ero1amyc6his-C94S were used. For unknown reasons, the monomeric form of transiently transfected Ero1amyc6his is more exposed than stably transfected Ero1amyc6his to DTT-mediated reduction (as indicated by enhanced conversion of OX2 into more reduced, slower migrating forms). The result is representative of two independent experiments. Asterisk, Ero1amyc6his-ERp57 mixed-disulphide complex (compare Supplementary Figure S5 ).
fibroblasts (Dias-Gunasekara et al, 2005; Zito et al, 2010) , this pathway is exclusively supported by the Ero1a isoform. In addition, the results show that-in spite of the oxidative burst in the ER after DTT treatment-accumulation of GSSG is very tightly regulated. Thus, the cellular GSSG:GS tot ratio levels off to the steady-state value within a few minutes. This rapid process could neither be explained through import of GSH or nascent proteins from the cytosol, nor by the escape of disulphide-bonded molecules from the ER through the secretory pathway (Figure 1) . Likewise, the diffusion of excess GSSG through the ER membrane is far too slow to efficiently counteract the luminal oxidation of GSH (Banhegyi et al, 1999) . Instead, we propose that the prompt regulation of GSSG levels involves ER-luminal reduction of GSSG to GSH (see below). The remarkable precision of GSSG:GS tot regulation exemplifies the stringent redox control system in the ER. Here, PDI fulfils a central function in regulating ER redox conditions by its ability to adjust the activation state of Ero1a (AppenzellerHerzog et al, 2008) . Moreover, glutathione is known to be important for ER redox homeostasis, as its depletion compromises oxidative protein folding (Chakravarthi and Bulleid, 2004; Molteni et al, 2004) and sensitizes the ER to overexpression of Ero1 (Appenzeller-Herzog et al, 2008) . A model depicting central elements of ER redox regulation that integrates the PDI-Ero1a feedback loop with the redox buffering capacity of glutathione is presented in Figure 7 . We propose that a dynamic equilibrium exists between Ero1a-driven ( Figure 7A ) and GSSG-driven ( Figure 7B ) oxidation of substrate proteins through PDI-family members. In the context of de novo disulphide formation driven by Ero1a, GSH is oxidized to GSSG. Rising levels of GSSG will promote GSSGdriven oxidation of PDIs and also shutdown of Ero1a. The interplay between the two oxidative pathways that either produce ( Figure 7A ) or consume ( Figure 7B ) ER-luminal GSSG maintains ER redox homeostasis by establishing a system that can adapt to physiological changes in the throughput of substrate proteins. It should be noted that this model does not exclude the contribution from Ero1-independent oxidative pathways (see also below). However, the exact influence on ER redox control of such pathways awaits further investigation.
The model is supported by our experiments using overexpression of Ero1 variants. The transient overshoot in GSH oxidation upon DTT washout resulting from the induction of Ero1amyc6his ( Figure 4C ) serves to illustrate both of the pathways depicted in Figure 7 . Hence, upon DTT-mediated breaking of the regulatory disulphides in Ero1a, the enzyme is present in its activated form, which-when overexpressed-will catalyse excess production of GSSG through PDI. This process is, however, rapidly reverted. As indicated by the slightly delayed drop of GSSG:GS tot in Ero1amyc6his-C131A-expressing cells compared with wild type ( Figure 4C and E), oxidative shutdown of Ero1a by the Cys 94 -Cys 131 regulatory disulphide (Appenzeller-Herzog et al, 2008; Baker et al, 2008) apparently modulates the process. A comparable delay in GSSG peak formation after DTT washout was observed upon over-expression of Ero1bmyc6his ( Figure 4D ), which-like Ero1amyc6his-C131A-is partially deregulated (Appenzeller-Herzog et al, 2008) . As GSSG levels still declined in both Ero1amyc6his-C131A and Ero1bmyc6his cells, these experiments also point to the existence of additional regulatory disulphide bonds in Ero1a and Ero1b, for example the equivalent of Cys 90 -Cys 349 in Ero1p (Sevier et al, 2007) . These in turn appear to be more stable in Ero1b, as evidenced by the less prominent formation of GSSG in Ero1bmyc6his cells upon DTT washout.
The decline of GSSG:GS tot in Ero1-over-expressing cells, however, cannot solely be explained by the shutdown of Ero1 activity, but must also involve reduction of GSSG. On the basis of in vitro kinetics, it has been proposed that GSSG in the ER preferentially reacts with reduced PDIs as compared with folding substrate proteins (Hatahet and Ruddock, 2009 ). Still, TMX3 and ERp57-as putative electron sources for GSSG-were never completely oxidized during oxidative recovery in both Ero1amyc6his-and Ero1bmyc6his-expressing Figure 7 Model for glutathione-buffered ER redox homeostasis. Graphical depiction of two disulphide relay pathways that both lead to the oxidation of nascent proteins (substrate) in the ER. (A) In the Ero1a-driven oxidation pathway for de novo disulphide formation, oxidizing equivalents are transferred from O 2 to Ero1a that in turn oxidizes PDI. The byproduct H 2 O 2 (Wang et al, 2009; Enyedi et al, 2010) can also oxidize PDI yielding two molecules of H 2 O (Karala et al, 2009) . A potential in vivo catalyst of this reaction remains to be identified (question mark). Abundant levels of reduced PDI keep Ero1a in an active state (green arrow) (Appenzeller-Herzog et al, 2008) . Being the main substrate of Ero1a, disulphides are passed on primarily to PDI, but other PDIfamily members (PDIs) may also participate to some extent in this pathway. GSH competes with substrate for reaction with oxidized PDI, resulting in the formation of GSSG. (B) GSSG-driven oxidation of reduced PDIs (yellow arrows) will be prominent when ER GSSG is abundant, which will also promote shutdown of Ero1a because of low availability of reduced PDI. Similar to the Ero1a-driven oxidation pathway, the PDIs will then oxidize substrate proteins (blue arrows). The interplay between the two pathways depends on the redox state of the glutathione redox couple in the ER. For instance, during oxidative recovery after DTT treatment de novo disulphide generation is dominant immediately after DTT washout. However, as GSSG levels rise, the GSSG-driven oxidation pathway will become increasingly more prominent until homeostasis is reinstalled. For simplicity, the scheme only illustrates the net flow of oxidizing equivalents onto substrate and excludes the reduction of, for example, aberrantly disulphide-bonded substrates by PDIs. Likewise, the direct reaction of GSSG with reduced substrates that results in glutathionylated substrates (Bass et al, 2004; Hansen et al, 2009 ) has been omitted. The model does not account for the contribution to ER thiol-disulphide homeostasis by Ero1-independent pathway(s) as the exact nature of these is not yet known. Red, reduced; ox, oxidized. Figure S3C) . A potential explanation for this observation could be that the PDIs rapidly pass on GSSGderived disulphides to substrate proteins.
cells (Supplementary
We suggest that GSSG-driven oxidation of PDIs also takes place in non-transfected cells to control redox homeostasis ( Figure 7B ). For instance, TMX3, which is readily oxidized by GSSG in vitro (Haugstetter et al, 2007) , but not found in mixed-disulphide complexes with Ero1 ( Figure 3D ), showed rapid, Ero1a-dependent reoxidation upon DTT washout (Supplementary Figure S4B) , presumably as a result of oxidation by GSSG. Altogether, we propose that the reaction of GSSG with reduced PDIs followed by substrate oxidation (Lyles and Gilbert, 1991; Zapun et al, 1998) , a pathway that has received little attention since the discovery of Ero1, is of physiological relevance for oxidative protein folding and ER redox homeostasis.
The in vivo rate of Ero1-mediated disulphide generation is unexpectedly fast
The rapid kinetics of redox recovery after DTT washout observed here was unexpected as previously published data from mammalian (Mezghrani et al, 2001; Enyedi et al, 2010) and yeast cells (Cuozzo and Kaiser, 1999) reported the rate of Ero1-dependent ER reoxidation to be much slower. How can this be explained? In our experiments, we observed that the millimolar concentrations of DTT necessary to fully reduce GSSG and ER oxidoreductases in situ are difficult to wash away. Therefore, the slow recovery kinetics previously observed could in part have been due to residual DTT in the sample. In addition, the oxidation state of cellular glutathione in yeast at 'time point zero' after DTT washout was not-as should be expected after DTT treatment-fully reduced (Cuozzo and Kaiser, 1999; Sevier et al, 2007; P N^rgaard and JR Winther, personal communication) . This suggests that considerable amounts of GSSG had already formed in the ER before quenching. The subsequent slow increase of GSSG could potentially reflect the vacuolar accumulation of ERderived GSSG.
When assessed in vitro, the reaction kinetics of thioldisulphide exchange between Ero1a and PDI are surprisingly slow compared with the rapid reaction in the ER during DTT washout (Baker et al, 2008; Wang et al, 2009) . A partial explanation is offered by the shutdown of Ero1a activity through formation of intramolecular disulphide bonds (Appenzeller-Herzog et al, 2008; Baker et al, 2008) . Accordingly, the bulk of purified Ero1a used for in vitro assays is in the inactive state (Baker et al, 2008) , whereas cellular Ero1a is fully activated by DTT at the start of the recovery period. Although PDI is involved in their regulation in vivo (Appenzeller-Herzog et al, 2008) , the protein is not sufficiently reducing to effectively open the stable regulatory disulphide bonds in Ero1a (Baker et al, 2008) . Addition of GSH to maintain PDI in the reduced form or replacement of PDI with the more reducing thioredoxin more efficiently activated Ero1a and increased the reaction kinetics (Baker et al, 2008) , but still failed to reproduce the rapid pace of oxidation observed in cells. It, therefore, appears that the in vitro experiments do not faithfully reproduce the situation in the ER where additional factors such as the ionic composition of the solvent (e.g. the levels of calcium), conformational changes in Ero1a induced by an as yet unknown protein, the two N-glycans in Ero1a or the catalysed metabolic discharge of reaction products such as hydrogen peroxide could have important functions.
PDI is the major, but probably not the only substrate of Ero1
Using acid quenching to trap mixed-disulphide complexes, we identify ERp57 and ERp72 as novel interactors of Ero1a and b. Multiple lines of evidence, however, point to PDI as being the principal interaction partner of Ero1: (1) as opposed to ERp57, PDI is unambiguously required for efficient ER reoxidation after DTT treatment ( Figure 5E -H); (2) overexpression of Ero1a does not affect the cellular redox state of ERp57 while easily oxidizing PDI (Mezghrani et al, 2001; Appenzeller-Herzog et al, 2008) ; (3) PDIa 0 is significantly more resistant than ERp57a 0 towards in situ reduction by DTT ( Figure 2) ; (4) the amount of acid-trapped PDI co-immunoprecipitating with Ero1 is relatively higher than that of ERp57 and ERp72 ( Figure 3) ; (5) on non-reducing aEro1a western blots after acid trapping, the mixed disulphide with PDI is the predominant high-molecular weight species ( Figure 6B ); (6) depletion and over-expression of PDI, but not of other PDIfamily members, modulate the formation of the regulatory disulphide bonds in Ero1a (Appenzeller-Herzog et al, 2008; K Araki and K Nagata, personal communication) and (7) among several PDIs that interact with Ero1a in cells, PDI itself is the best substrate in an in vitro activity assay and shows the highest affinity for Ero1a (K Araki and K Nagata, personal communication).
Owing to the lower prevalence of the ERp57 and ERp72 complexes with Ero1, the functional implications of these interactions are currently unclear. Still, the increased resistance of ERp57 towards in situ reduction by DTT as compared with TMX3 ( Figure 2C ) and the significant delay in GSSG reformation upon DTT washout in ERp57À/À cells ( Figure 5H ) argue that at least under certain conditions, ERp57 can accept disulphide bonds from Ero1, as has also been observed in vitro (Kulp et al, 2006; K Araki and K Nagata, personal communication) .
We have shown that the PDI-Ero1a/b mixed disulphide in cells at steady state predominantly involves an oxidized form of Ero1 (Figure 6 ). It is noteworthy that both PDI and ERp57 also interacted with the active-site mutant Ero1a-C94S at steady state (data not shown). It was only in DTT-treated cells that formation of the PDI-Ero1a mixed disulphide became strictly dependent on Cys 94 ( Figure 6C ). Owing to the typically short-lived nature of a mixed disulphide during thiol-disulphide exchange (e.g. see Darby and Creighton, 1995) , and since it is the reduced form of Ero1a that is engaged in disulphide transfer to substrate (Baker et al, 2008) , we reason that the surprisingly abundant Ero1 complexes at steady state do not represent catalytic reaction intermediates. It thus seems that PDI-related oxidoreductases as well as PDI itself are engaged in as yet uncharacterized mixed-disulphide interactions with Ero1.
Ero1-independent disulphide-bond formation
Murine B-cells depleted of both Ero1 isoforms unexpectedly secrete nearly normal levels of disulphide-bonded immunoglobulins (Zito et al, 2010) . The results obtained here with ERO1 double mutant cells also provide strong evidence for Ero1-independent generation of disulphides, which may explain the viability of these cells (for a recent review, see Margittai and Banhegyi, 2010) . Although we are currently lacking an explanation for these observations, it is worth noting the different reoxidation kinetics of cellular GSH and of the ER enzyme ERp57 after reduction in Ero1-deficient cells ( Figure 5B and D) . In addition, these cells display a disturbed glutathione homeostasis as indicated by a higher GSSG:GS tot ( Figure 5D ) and a lower concentration of GS tot (our unpublished observations). The exact nature of Ero1-independent pathways and their importance in cells harbouring an intact Ero1 system will be important topics for future investigation. It is conceivable that such studies will reveal additional important elements of ER redox homeostasis that must be integrated into our current thinking about this process (Figure 7) . Despite all of this, the powerful capability of over-expressed Ero1a to boost GSH reoxidation ( Figure 4C ) along with the delayed ER reoxidation in ERO1 double mutant cells ( Figure 5C ) clearly indicates a prominent function of Ero1 oxidases in the net generation of disulphides in the mammalian ER.
In conclusion, the present results emphasize the significance of electron flow from PDI to Ero1 for effective ER oxidation in mammalian cells. Moreover, the data indicate that a dynamic equilibrium between Ero1-and GSSG-driven substrate protein oxidation through PDIs constitutes a central element of ER redox control.
Materials and methods
Recombinant DNA
For generation of the C94S mutant of Ero1a, we used pcDNA3.1/ Ero1a-myc6his ; a gift from R Sitia, Milan) as a template for QuikChange mutagenesis (Stratagene) using the primer pair 5 0 -GAATGACATCAGCCAGTCTGGAAGAAGGGACTG-3 0 / 5 0 -CAGTCCCTTCTTCCAGACTGGCTGATGTCATTC-3 0 . pcDNA3/HA-ERp 57SS1 (encoding ERp57 SXXS-CXXC) and pcDNA3/HA-ERp57SS2 (encoding ERp57 CXXC-SXXS) were produced by two consecutive rounds of QuikChange using pcDNA3/HA-ERp57 (Otsu et al, 2006 ; a gift from R Sitia, Milan) as template. The primer pairs were: first round SS1:
Cell culture, transfection, drug treatment and antibodies
The culturing of HEK293, Flp-In TRex-293 cells for doxycyclininducible expression of Ero1 variants (or transfected with empty pcDNA5/FRT/TO vector; negative control cells) and HeLa-derived PDI shRNA cells (Ou and Silver, 2006) has been described (Appenzeller-Herzog et al, 2008) . Immortalized embryonic fibroblasts were prepared from wild-type and Ero1a/Ero1b double mutant mice (Zito et al, 2010) and cultivated in Dulbecco's-modified eagle medium (4.5 g/l glucose) supplemented with 1% nonessential amino acids and 10% foetal calf serum. 2175 þ (ERp57 þ / þ ) and 2175 À (ERp57À/À) mouse fibroblast cells (Garbi et al, 2006) were grown in a-minimal essential medium (Invitrogen) containing 10% foetal calf serum. Transient transfection of cDNA was performed using Lipofectamine 2000 and of siRNA using Lipofectamine RNAiMAX (both Invitrogen). The following siRNAs were used (Qiagen, final concentrations in brackets): negative control siRNA 1022076 (20 nM) and Hs_ER-O1L_5 HP against Ero1a (20 nM). BFA and monensin (both Sigma) were used at a concentration of 5 mg/ml and 100 nM, respectively. For the depletion of glutathione or nascent proteins, the cells were treated with 1 mM BSO for 20 h or 100 mg/ml CHX for 3 h (both Sigma). DTT resistance experiments were carried out using a fresh, aqueous DTT stock solution that was calibrated in 50 mM NaPO 4 , pH 7.3, 0.1 mM EDTA using 5,5 0 -dithiobis(2-nitrobenzoic acid) (DTNB; 1 mM; e 412 14 150 M À1 cm À1 ). Cells were then incubated in full growth medium containing defined DTT concentrations for 10 min at 371C.
The following mouse monoclonal antibodies were used: 9E10 (amyc, Covance), AC-15 (aactin, Sigma), HA.11 (aHA, Covance) and RL90 (aPDI, abcam). The rabbit polyclonal antisera used were as follows: aTMX3 (Haugstetter et al, 2005) , aERp57 (a gift from A Helenius, Zü rich), SPA-890 (aPDI, Stressgen), SPS-720 (aERp72, Stressgen) and aEro1a (D5, a gift from I Braakman, Utrecht).
Assays for the in vivo redox states of PDIs and glutathione Protocols for alkylation of originally oxidized cysteines with methoxy polyethylene glycol 5000 maleimide (mPEG-mal) or AMS have been published (Appenzeller-Herzog and Ellgaard, 2008a) . The cellular GSSG:GSH ratio was measured using a DTNB/ glutathione reductase recycling assay as previously described (Appenzeller-Herzog et al, 2008) .
In situ acid trapping, immunoprecipitation and concanavalin A precipitation Cells induced with 1 mg/ml doxycyclin for 24 h, pulsed with 35 Smethionine (Perkin Elmer) for 1 h in the presence of doxycyclin and chased for 1 h with 10 mM cold methionine in the presence or absence of 100 mg/ml CHX were washed with cold PBS, covered with 10% TCA and incubated on ice for 15 min. The precipitated cell material was then scraped from the culture dish with a rubber policeman, pelleted at 20 000 g at 41C for 15 min and the pellet covered with a solution containing 58 mM Tris/HCl pH 7, 27% dimethyl sulphoxide, 7.3% glycerol, 1.5% SDS, 15 mM NEM, 0.2 mM phenylmethylsulphonylfluoride and 0.1% bromcresol purple. After neutralization of the supernatant by dropwise addition of 1 M Tris/Cl, pH 8 until the solution turned purple, the pellet was solubilized using a microsonicator equipped with a 0.5 mm sonotrode (Hielscher Ultrasound Technology, Teltow, Germany) followed by incubation at room temperature for 1 h. Ten sample volumes of cold 30 mM Tris/HCl, pH 8.1, 100 mM NaCl, 5 mM EDTA and 2% Triton X-100 were then added, and the lysate processed for amyc immunoprecipitation as described previously (AppenzellerHerzog and Ellgaard, 2008a) . Immunoprecipitates were analysed by reducing or non-reducing SDS-PAGE and western blotting, followed by exposure of the western blot membrane to a phosphor screen (GE Healthcare) for autoradiography. Ahead of precipitation using concanavalin A (ConA)-sepharose (Sigma), SDS-lysates of TCA pellets were mixed with 10 volumes of 100 mM NaPO 4 , pH 6.8, 1.5% TX-100.
DTT washout assays
For measuring the recovery of cellular GSSG levels after DTT treatment, the cells were grown in 10 cm dishes and incubated for 5 min in medium containing 10 mM DTT. The cell monolayers were then quickly washed twice with 5 ml of PBS at room temperature (a step taking B30 s) and, for oxidative recovery, covered again with PBS (defined as the 0 s time point). The reaction was stopped by the removal of PBS and the addition of ice-cold 1% sulphosalicylic acid.
For visualization of the TMX3 and ERp57 redox states upon DTT washout, the cells were grown on plastic coverslips (diameter B30 mm, placed in a six-well dish) that had been excised from 35 mm cell culture dishes and sterilized by UV light. DTT treatment (1 mM) was for 5 min at 371C in growth medium. Subsequently, the coverslips were picked with forceps, drained on a paper towel, consecutively dipped into three beakers containing 371C PBS (for B1 s each) and into another warm PBS bathing solution for the indicated periods. For the 0 s time point, this last incubation step was omitted. Oxidative recovery was terminated by dipping the coverslips into ice-cold PBS containing 20 mM NEM. After a 20 min incubation in NEM buffer on ice, the cells were further processed for AMS alkylation.
Densitometric analyses
To evaluate the results obtained by the AMS assay, the ratios of oxidized to reduced species on aTMX3 and aERp57 western blots were analysed by densitometry using the ImageJ software (available at http://rsbweb.nih.gov/ij). Of note, the steady-state redox states of both TMX3 and ERp57 varied between individual experiments, which likely reflected physiological fluctuations rather than low reliability of the AMS assay (see the diamide control lanes). To normalize for these variations we, therefore, expressed the oxidized fractions as percentage of the oxidized fraction in the steady-state lane of the same experiment.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
